Bd, certest biotec announce commercial launch of monkeypox test

Research use only (ruo) assay now available for bd max™ system users franklin lakes, n.j. , july 27, 2022 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, and certest biotec today announced their newly developed molecular polymerase chain reaction (pcr) test for the monkeypox virus is now commercially available outside of the united states for use in research applications by laboratories.
BDX Ratings Summary
BDX Quant Ranking